Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas
Year: 2019
Type: article
Study design: Observational Study
Source: Journal of Thoracic Oncology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Mesothelioma Applied Research Foundation, Bristol-Myers Squibb, International Business Machines Corporation, Pfizer, AstraZeneca, Merck, Roche, AbbVie, Aldeyra Therapeutics, Daiichi-Sankyo, MedImmune, National Institutes of Health, Helsinn Therapeutics, National Cancer Institute
OpenAlex ID: W2997140575
